期刊文献+

甲羟孕酮对年轻子宫内膜不典型增生患者的疗效研究 被引量:6

Clinical Study of Medroxyprogesterone in the Treatment of Young Patients with Endometrial Atypical Hyperplasia
下载PDF
导出
摘要 目的探讨甲羟孕酮对年轻子宫内膜不典型增生患者的疗效。方法 115例子宫内膜不典型增生患者,轻度、中度和重度不典型增生分别为63、32和20例。所有患者经诊断性刮宫病理检查确诊,应用甲羟孕酮治疗3~6个月后,行诊刮送病理检查以评价其疗效,记录有生育要求患者妊娠情况。结果 115例患者经甲羟孕酮治疗后,109例有效,总有效率达94.7%,轻度、中度和重度子宫内膜不典型增生患者有效率分别为100.0%、93.7%和70.0%,轻度和中度患者总有效率显著高于重度患者,差异有统计学意义(P<0.05)。95例有生育要求的患者治疗后64例达临床妊娠,其中轻度患者42例,中度患者15例,重度患者7例,轻度、中度和重度患者妊娠率分别为73.6%、60.0%和53.8%,三组妊娠率比较无统计学差异(P>0.05)。结论对有生育要求的年轻子宫内膜不典型增生患者,采用甲羟孕酮保守治疗的效果好,不仅能够有效治疗疾病,而且能够提高患者生活质量,达到生育目的,但要注意密切随访预防复发。 Objective To study the effects of medroxyprogesterone in young patients with endometrial hyperplasia.Methods 115 patients with endometrial hyperplasia were divided into mild,moderate and severe hyperplasia with 63,32 and 20 cases,respectively.All patients were dignosed and confirmed by pathological examination.The efficacy was evaluated after treatment with medroxyprogesterone for 3-6 months by pathological examination.The pregnancy situation was recorded for patients having fertility requirements.Results There were 109 positive cases in 115 patients after treated by medroxyprogesterone.The total efficiency rate was 94.7%.The efficiency rate in mild,moderate and severe endometrial atypical hyperplasia were 100.0%,93.7% and 70.0% respectively.The positive rates for patients with mild and moderate endometrial hyperplasia were significantly higher than patients with severe endometrial atypical hyperplasia.There was significant difference(P0.05).64 patients achieved clinical pregnancy after treatment in 95 patients with fertility requirements,including 42 cases in mild,15 cases in moderate and 7 cases in severe hyperplasia.The pregnancy rates for patients with mild,moderate and severe endometrial hyperplasia were 73.6%,60.0% and 53.8% respectively,there was no significant difference(P0.05).Conclusion Medroxyprogesterone is effective for young patients with endometrial hyperplasia and having pregnancy requirements.Medroxyprogesterone can not only treat the disease effectively,but also improve the quality of patients' life and achieve the purpose of reproduction.We should pay close attention to the follow-up to prevent recurrence.
出处 《实用癌症杂志》 2013年第3期266-268,共3页 The Practical Journal of Cancer
关键词 子宫内膜不典型增生 年轻 甲羟孕酮 保守治疗 Endometrial atypical hyperplasia Young Medroxyprogesterone Conservative treatment
  • 相关文献

参考文献13

  • 1徐晓颖,邵卫仙,李国权,李杰.影响子宫内膜癌术后放疗疗效的相关因素分析[J].实用癌症杂志,2010,25(6):652-656. 被引量:14
  • 2Hahn HS, Yoon SG, Hong JS, et al. Conservative treatment with progestin and pregnancy outcomes in endometrial canc- er[ J ]. Int J Gynecol Cancer,2009,19 (6): 1068.
  • 3陈洁,潘青荣,陈俊琦.甲羟孕酮治疗子宫内膜不典型增生的短期疗效观察——附43例报告[J].新医学,2009,40(8):536-537. 被引量:11
  • 4Lacey JV Jr,Sherman ME, Rush BB,et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia [ J ]. J Clin Oncol, 2010,28 ( 5 ) :788.
  • 5Signorelli M, Caspani G, Bonazzi C, et al. Fertility-sparing treatment in young women with endometrial cancer or atypi- cal complex hyperpiasia:a prospective single-institution ex-perience of 21 cases[J]. BJOG,2009,116(1):114.
  • 6Rohan TE, Negassa A, Chlebowski RT, et al. Estrogen plus progestin and risk of benign proliferative breast disease [J]. Cancer Epidemiol Biomarkers Prey, 2008, 17 (9) : 2337.
  • 7Lee SY, Kim MK, Park H, et al. The effectiveness of 1- evonorgestrei releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women [J]. Gynecol 0ncol,2010,21 (2) : 102.
  • 8叶思款,季波,吴佩兹,张丽梅.醋酸甲羟孕酮的药理作用与临床应用[J].中国药业,2010,19(1):63-64. 被引量:27
  • 9俞梅,沈铿,杨佳欣,黄惠芳,吴鸣,潘凌亚,郎景和,连利娟.高分化子宫内膜样癌及子宫内膜重度不典型增生患者孕激素治疗的临床分析[J].中华妇产科杂志,2006,41(4):242-245. 被引量:28
  • 10Orbo A,Ames M,Pettersen I, et al. Down-regulated proges- terone receptor A and B coinciding with successful treat- ment of endometrial hyperplasia by the levonorgestrel im- pregnated intrauterine system [ J ]. Acta Obstet Gynecol Scand, 2010,89 ( 11 ) : 1438.

二级参考文献41

  • 1金鑫.甲羟孕酮致过敏反应一例[J].药学服务与研究,2002,2(z1):306-306. 被引量:5
  • 2王伟军,王强,张伟,屠小卿,张玲珍,范列英.醋酸甲羟孕酮对人结肠癌LS174T细胞体内生长抑制的作用[J].实用癌症杂志,2005,20(3):242-245. 被引量:1
  • 3蒋丽芳,田先芝,扬淑玲,李秀娟,陈予梅,王鹏辉,李培全.长效醋酸甲羟孕酮治疗巧克力囊肿25例临床效果观察[J].中国全科医学,2006,9(14):1195-1196. 被引量:1
  • 4蒋鹏程,施如霞.106例子宫内膜癌术后联合放射治疗疗效及预后因素分析[J].中国肿瘤,2006,15(11):792-794. 被引量:4
  • 5GOTLIEB W H, BEINER M E, SHALMON B, et al. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer[JJ. Obstet Gynecol, 2003, 102 (4): 718-725.
  • 6OTA T, YOSHIDA M, KIMURA M, et al. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger [ J]. Int J Gynecol Cancer, 2005, 15 (4): 657-662.
  • 7NIWA K, TAGAMI K, LIAN Z, et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas[J]. BJOG, 2005, 112 (3) : 317-320.
  • 8RAMIREZ P T, FRUMOVITZ M, BODURKA D C, et al. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review [ J ]. Gynecol Oncol, 2004, 95 (1) : 133-138.
  • 9四川美康医药软件开发有限公司.药物临床信息参考[M].重庆:重庆出版集团.2007:1087-1088.
  • 10Jennifer Balkus, Leslie Miller. Same -day administration of depot -medroxy- progesterone acetate injection: a retrospective chart review[J]. Contrace ption, 2005, 71 ( 5 ) :395 - 398.

共引文献94

同被引文献50

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部